Wolverine Trading
NAGE

Wolverine Trading’s Niagen Bioscience NAGE Stock Holding History

Wolverine Trading’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,800
Closed -$168K – 6330
2025
Q2 		$168K Buy
+11,800
New +$117K ﹤0.01% 3995
2021
Q4 		– Sell
-22,800
Closed -$138K – 7045
2021
Q3 		$138K Sell
22,800
-2,000
-8% -$16.5K ﹤0.01% 5600
2021
Q2 		$236K Buy
24,800
+3,200
+15% +$27.9K ﹤0.01% 4799
2021
Q1 		$190K Buy
+21,600
New +$171K ﹤0.01% 5088

Other funds holding NAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wolverine Trading's NAGE Position: Q3 2024 in Review

Wolverine Trading sold out of Niagen Bioscience (NAGE) in Q3 2024, closing a stake of 28,841 shares — an estimated $90.8K sold.

Wolverine Trading first reported a position in NAGE in Q2 2021 and held it in 3 quarters. The position peaked at $154K in Q1 2024. 91 funds tracked by Wall St. Rank hold NAGE as of Q3 2024.

  • Wolverine Trading reported no remaining Niagen Bioscience position as of Q3 2024 after selling out during the quarter.
  • Wolverine Trading sold 28,841 Niagen Bioscience shares in Q3 2024, an estimated $90.8K.
  • Wolverine Trading first reported a position in Niagen Bioscience in Q2 2021 and held it in 3 quarters.
  • Wolverine Trading's Niagen Bioscience position peaked at $154K in Q1 2024.
  • 91 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2024.

Based on Wolverine Trading's 13F filing for Q3 2024, filed 14 Nov 2024.